Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Ascendis Pharma and Novo Nordisk Partner on TransCon Technology for Metabolic and Cardiovascular Treatments
Tuesday, November 05, 2024Ascendis Pharma has granted Novo Nordisk AS an exclusive worldwide license for its TransCon technology platform to advance Novo Nordisk products in metabolic diseases including obesity and type diabetes and on a productbyproduct basis for cardiovasc...
Y-mAbs Enters into Agreement with Nobelpharma for Exclusive DANYELZA® Licensing in Japan
Tuesday, November 05, 2024YmAbs Therapeutics has entered an exclusive licensing and distribution agreement with Nobelpharma This partnership aims to develop and potentially commercialise DANYELZA for the treatment of relapsed or refractory highrisk neuroblastoma in Japan and...
Leica Biosystems and CST Partner for Flexible High-Throughput Spatial Biology
Monday, November 04, 2024Leica Biosystems has announced a partnership with Cell Signaling Technology CST The BOND RX staining platform allows researchers to fully automate new technologies customize all parts of the protocol and implement their ideas effectively
VALANX Biotech and Fina Biosolutions Collaborate to Accelerate Conjugate Vaccine Development
Saturday, November 02, 2024VALANX Biotech and Fina Biosolutions have joined forces to develop a new product ClickCRM designed to streamline the production of conjugate vaccines ClickCRM is a modified version of the widely used carrier protein CRM
Hansoh Pharma Gains NMPA Breakthrough Therapy for HS-20093 in Lung Cancer Treatment
Saturday, November 02, 2024Hansoh Pharmaceutical announced that its inhouse developed antibodydrug conjugate ADC HS has been granted Breakthrough Therapy Designation by Chinas National Medical Products Administration NMPA
CStone's Sugemalimab Approved for First-Line NSCLC Treatment in UK
Friday, November 01, 2024CStone Pharmaceuticals has announced that the UK Medicines and Healthcare products Regulatory Agency MHRA has approved sugemalimab Sugemalimab is a unique antiPDL monoclonal antibody developed by CStone using its proprietary OmniRat technology
Teijin and Hilleman Laboratories Partner to Advance Cell and Gene Therapy CDMO
Friday, November 01, 2024Teijin Limited and Hilleman Laboratories have announced a strategic partnership to expand their contract development and manufacturing organization CDMO business in the field of cell and gene therapy
AbbVie and EvolveImmune Partner to Develop Next-Generation Cancer Therapies
Friday, November 01, 2024AbbVie and EvolveImmune Therapeutics have announced a strategic partnership to develop nextgeneration cancer biotherapeutics This collaboration aims to address the significant unmet need for effective treatments
Tevogen Bio Partners with Microsoft to Speed Up Drug Development using AI
Friday, November 01, 2024Tevogen Bio has announced a partnership with Microsoft to utilise machine learning ML and Artificial Intelligence AI to accelerate their drug development process Firstly TevogenAI will leverage machine learning to analyse vast datasets across the hum...
Novartis’ Scemblix® Gains FDA Approval for Newly Diagnosed Chronic Myeloid Leukemia (CML)
Wednesday, October 30, 2024Novartis has announced that Scemblix asciminib received accelerated approval from the US Food and Drug Administration FDA for use in adult patients newly diagnosed with Philadelphia chromosomepositive chronic myeloid leukaemia in chronic phase Ph CML...
